February 2022 - Clever Leaves

The Australian Natural Therapeutics Group Signs a US$7.8M Product Agreement With Clever Leaves to Accelerate Medical Cannabis Access in Australia

Clever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis market

Clever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis market

Clever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis market

Clever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis market

Products imported and to be commercially available in German pharmacies

Products imported and to be commercially available in German pharmacies

Produkte sind bald in deutschen Apotheken erhältlich

Produkte sind bald in deutschen Apotheken erhältlich

The agreement will now include high-THC Flower from Portugal facilities and will allow for the expansion of its oral solution supply

The agreement will now include high-THC Flower from Portugal facilities and will allow for the expansion of its oral solution supply

Performance Delivers on 2021 Outlook and Provides Solid Foundation for 2022

Kyle Detwiler to Step Down as CEO; Andres Fajardo to be Appointed CEO

Kyle Detwiler to Step Down as CEO; Andres Fajardo to be Appointed CEO

Appointment Accompanied by One-Year Lock-Up for Schultze Special Purpose Acquisition Sponsor Shares

Appointment Accompanied by One-Year Lock-Up for Schultze Special Purpose Acquisition Sponsor Shares